Erivedge (Genentech)
(https://erivedge.com) 📸 Data Snapshot: May 30, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Authority is exceptionally high with zero gaps. The schema_json provides a complete Organization profile for Genentech, including a physical address in South San Francisco, a customer service contact point, and specific MedicalWebPage markup. The use of named case studies (Matt and Marsha) is grounded in clinical study parameters, although they lack individual Person schema or sameAs links to professional registries.
The ‘#1 most-prescribed’ claim is substantiated by a specific citation of IQVIA real-world data (Feb 2012–Aug 2025), which is a high-authority proof point. However, the disconnect lies in the age of the patient metrics; claiming market leadership in 2026 using case studies from 2010 suggests a lack of recent clinical substantiation in the narrative content.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.erivedge.com/",
"description": "Learn about Erivedge® (vismodegib) as a basal cell carcinoma treatment option for both metastatic and locally advanced carcinoma. See full safety and Boxed Warning for more information.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"dosageForm": [
"Capsule"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"alternateName": [
"aBCC"
]
}
]
}
]
/patient/side-effects/important-safety-information.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.erivedge.com/patient/side-effects/important-safety-information.html",
"description": "Read important safety information for Erivedge (visomodegib). See full safety & Boxed Warning. ",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Erivedge",
"nonProprietaryName": "Vismodegib",
"dosageForm": [
"Capsule"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Advanced Basal Cell Carcinoma",
"alternateName": [
"aBCC"
]
}
]
}
]
/patient/about-erivedge/how-it-works.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.erivedge.com/patient/about-erivedge/how-it-works.html",
"description": "Find out how Erivedge® (vismodegib) works to treat advanced basal cell carcinoma. See full safety & Boxed Warning.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Erivedge",
"nonProprietaryName": "Vismodegib",
"dosageForm": [
"Capsule"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Advanced Basal Cell Carcinoma",
"alternateName": [
"aBCC"
]
}
]
}
]
/patient/results-with-erivedge/patient-stories.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "schema.org",
"@type": "MedicalWebPage",
"url": "https://www.erivedge.com/patient/results-with-erivedge/patient-stories.html",
"description": "Explore results from real people who were treated with Erivedge® (vismodegib). See full safety & Boxed Warning.",
"MedicalAudience": "https://schema.org/Patient",
"about": [
{
"@type": "Drug",
"name": "Erivedge",
"nonProprietaryName": "Vismodegib",
"dosageForm": [
"Capsule"
],
"administrationRoute": [
"Oral"
]
},
{
"@type": "MedicalCondition",
"name": "Advanced Basal Cell Carcinoma",
"alternateName": [
"aBCC"
]
}
]
}
]
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /patient/side-effects/important-safety-information.html | 0 | 0 |
| /patient/about-erivedge/how-it-works.html | 2 | 0 |
| /patient/results-with-erivedge/patient-stories.html | 0 | 0 |
This page presents a snapshot of public data from Erivedge (Genentech), captured on May 30, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Erivedge (Genentech): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://erivedge.com to view the most current version of its content and see directly what this company is about and what it offers.